The stock of Concordia International Corp (TSE:CXR) reached all time low today, Nov, 1 and still has $3.68 target or 14.00% below today’s $4.28 share price. This indicates more downside for the $208.78 million company. This technical setup was reported by Barchart.com. If the $3.68 PT is reached, the company will be worth $29.23M less.
Trading stocks at an all time low is not easy. Stock at an all time low usually experience even more downside due to very negative fundament. Even thought the pullback rate is high, shorting is not an easy job because the risk of being wrong is big and the risk-reward ratio is always worse than if trading lon only. About 360,782 shares traded hands. Concordia International Corp (TSE:CXR) has declined 86.16% since March 28, 2016 and is downtrending. It has underperformed by 89.18% the S&P500.
Concordia International Corp (TSE:CXR) Ratings Coverage
Out of 4 analysts covering Concordia Healthcare Corp (TSE:CXR), 1 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 25% are positive. $135 is the highest target while $4.50 is the lowest. The $32.90 average target is 668.69% above today’s ($4.28) stock price. Concordia Healthcare Corp has been the topic of 23 analyst reports since August 11, 2015 according to StockzIntelligence Inc. RBC Capital Markets maintained the stock with “Outperform” rating in Tuesday, October 11 report. Goldman Sachs maintained the stock with “” rating in Friday, July 22 report. The company was maintained on Tuesday, August 11 by RBC Capital Markets. The rating was downgraded by Mackie to “Hold” on Thursday, December 3. The firm has “Outperform” rating by RBC Capital Markets given on Monday, October 31. The stock has “Outperform” rating given by RBC Capital Markets on Tuesday, June 7. The stock of Concordia International Corp (TSE:CXR) earned “Outperform” rating by RBC Capital Markets on Monday, October 17. RBC Capital Markets maintained the shares of CXR in a report on Monday, June 20 with “Outperform” rating. The rating was maintained by RBC Capital Markets with “Outperform” on Friday, January 8. Scotia Capital maintained the shares of CXR in a report on Wednesday, September 9 with “Sector Outperform” rating.
More notable recent Concordia International Corp (TSE:CXR) news were published by: Prnewswire.com which released: “Concordia International Corp. Announces Communication With CMA” on October 25, 2016, also Prnewswire.com with their article: “Concordia International Corp. Announces CEO Transition Plan” published on October 21, 2016, Prnewswire.com published: “Shareholder Class Action Filed Against Concordia International Corp. – CXRX” on August 17, 2016. More interesting news about Concordia International Corp (TSE:CXR) were released by: Business.Financialpost.com and their article: “Concordia International Corp takeover unlikely â€“ Goldman” published on September 27, 2016 as well as Prnewswire.com‘s news article titled: “Concordia International Corp. Announces FDA Approval for New Photofrin® Laser” with publication date: June 30, 2016.
Concordia International Corp, formerly Concordia Healthcare Corp, is a Canada pharmaceutical company. The company has a market cap of $208.78 million. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. It currently has negative earnings.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.